Identify patients who will progress at a 5-10x higher rate versus the current standard of care. Optimize management by informing care plan changes up to 55% of the time:
HIGH-RISK* – candidates for eradication therapy
LOW-RISK* – candidates for reduced surveillance
Precision Risk Stratification Generates
TissueCypher® delivers the holy grail of BE: predicting progression and non-progression.
Probability of Developing